Continuing challenges of sepsis research

被引:25
作者
Crowther, MA
Marshall, JC
机构
[1] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 2C4, Canada
[2] St Josephs Hosp, Dept Med, Hamilton, ON, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 286卷 / 15期
关键词
D O I
10.1001/jama.286.15.1894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1894 / 1896
页数:3
相关论文
共 15 条
[1]   Coagulation abnormalities in acute lung injury and sepsis [J].
Abraham, E .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 22 (04) :401-404
[2]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]   Why sepsis trials fail [J].
Bone, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07) :565-566
[4]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[5]   New strategies for clinical trials in patients with sepsis and septic shock [J].
Cohen, J ;
Guyatt, G ;
Bernard, GR ;
Calandra, T ;
Cook, D ;
Elbourne, D ;
Marshall, J ;
Nunn, A ;
Opal, S .
CRITICAL CARE MEDICINE, 2001, 29 (04) :880-886
[6]  
Dellinger RP, 1997, CHEST, V111, P744
[7]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[8]   Antithrombin III in patients with severe sepsis - A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis [J].
Eisele, B ;
Lamy, M ;
Thijs, LG ;
Keinecke, HO ;
Schuster, HP ;
Matthias, FR ;
Fourrier, F ;
Heinrichs, H ;
Delvos, U .
INTENSIVE CARE MEDICINE, 1998, 24 (07) :663-672
[9]   Antithrombin III in patients with severe sepsis: a pharmacokinetic study [J].
Ilias, W ;
List, W ;
Decruyenaere, J ;
Lignian, H ;
Knaub, S ;
Schindel, F ;
Keinecke, HO ;
Heinrichs, H ;
Thijs, LG .
INTENSIVE CARE MEDICINE, 2000, 26 (06) :704-715
[10]  
Marshall JC, 1999, SEPSIS, V3, P5